Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: HER2 Positive Breast Carcinoma|Stage IV Breast Cancer AJCC v6 and v7
Interventions: OTHER: Comprehensive Geriatric Assessment|OTHER: Laboratory Biomarker Analysis|DRUG: Neratinib|OTHER: Pharmacological Study
Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)